Copyright

(c) 2010-2024 Jon L Gelman, All Rights Reserved.

Monday, August 18, 2014

Banning Asbestos - WHO European Region Sets Plans

Today's post is shared from euro.who.int

Asbestos is one of the most severe and widespread environmental health hazards in the WHO European Region, and is responsible for half of fatal cancers linked to exposure at work. To discuss activities to put an end to asbestos-related diseases, representatives from 16 Member States in the WHO European Region and experts in occupational health and cancer registries met in Bonn, Germany, on 10–11 June 2014.
Photo Credit: WHO
Participants at a meeting on asbestos
elimination in Bonn, Germany, on 10-11 June 2014

They evaluated progress made since the 2010 Parma Declaration and emphasized the need for WHO support to develop national programmes on asbestos elimination. The Parma Declaration commits governments in the European Region to take action on a range of environmental issues affecting health. This includes commitments to act on the identified risks of exposure to carcinogens, including asbestos, and to develop national programmes for the elimination of asbestos-related diseases by 2015, in collaboration with WHO and the International Labour Organization (ILO).

Asbestos: a silent killer

More than 107 000 people worldwide die every year from asbestos exposure at work. This insidious killer generates fatal diseases such as lung cancer, mesothelioma and asbestosis several decades after exposure.

In the European Region 37 countries have banned the use of all forms of asbestos, following WHO and ILO recommendations. Nevertheless, an estimated 300 million people are still exposed to asbestos at work, as well as out of work. In some countries asbestos is still produced, traded and used.

The most efficient way to eliminate asbestos-related diseases is to stop the use of all forms of asbestos because:
  • there is no safe level of asbestos exposure
  • cancer risks are increased even with very low-level exposures
  • all forms of asbestos are carcinogenic to humans
  • asbestos can be substituted with safer materials.

Asbestos-free zone – the way forward

During the meeting participants highlighted the need to establish proper national registers on occupational diseases and on cancers, in order to:
  • assess national situations
  • promote action and take appropriate measures
  • raise awareness on the issues among policy-makers and the general population.

Training for health care practitioners in detecting and reporting asbestos-related diseases should be introduced or strengthened to track the link between exposure and disease and to gather proper data.

Issues related to asbestos removal were also discussed; this led Member States to ask for support to develop waste management strategies and to identify asbestos substitutes.

The meeting was hosted by the WHO European Centre for Environment and Health and co-financed by the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB).

….
Jon L. Gelman of Wayne NJ is the author of NJ Workers’ Compensation Law (West-Thompson-Reuters) and co-author of the national treatise, Modern Workers’ Compensation Law (West-Thompson-Reuters). For over 4 decades the Law Offices of Jon L Gelman  1.973.696.7900  jon@gelmans.com  have been representing injured workers and their families who have suffered occupational accidents and illnesses.

State Sen. Leland Yee allegedly solicited bribes for NFL Workers’ Compensation Law

The NFL controversy involving workers' compensation claims continues to heat up. Today's post by Brett Gowen of the California Bar is shared from fbgslaw.com
Brett Gowen


As part of the ongoing saga of State Senator Leland Yee, a new charge for racketeering was given by a federal grand jury. As part of the indictment, Sen. Yee allegedly solicited $60,000 for Yee’s vote and another senator’s vote on a bill dealing with limiting workers’ compensation benefits for NFL players. According to the indictment, Sen. Yee believed the money would be paid by a NFL team owner according to an LA Times article.

Attorney, Melissa Brown at Fraulob Brown Gowen & Snapp, has a connection to the NFL and their treatment of injured players. Ms. Brown was retained as an expert witness for the NFL Players’ Association at an arbitration hearing involving a workers’ compensation law dispute with NFL owners. The arbitration, and the flurry of lawsuits involving NFL injuries, is part of the growing recognition of the impact the game has on the long-term health of the players. 

California Medical Fraud Investigation Continues

"Follow the money." The investigation of fraud in the California Workers' Compensation system continues. Today's post of Julius Young of the California Bar
is shared from workerscompzone.com

You might have thought that news of bad behavior in California’s workers’ comp system was hitting bottom.

After all, could it get worse? Allegations of legislators taking money to help charlatans who profited off of the backs of injured workers (literally). Scads of doctors alleged to have taken kickbacks for prescribing questionable compound medicines one of which allegedly killed a baby.

It appears that law enforcement authorities are now focusing on relationships between some applicant attorney firms and medical groups.

In Southern California the Riverside County DA has executed a search warrant against a workers’ comp firm, California Injury Lawyers (CIL). Apparently this is a result of a long investigation into suspected workers’ comp fraud, targeting operations allegedly connected to an individual named Peyman Heidary who is said to have a financial interest in as many as nine medical clinics in the Los Angeles area.

The details of the alleged bad behavior or fraud is unclear, and it must be noted that any allegations are currently just that, allegations.

[Click here to read more]

3 Liberian Health Workers With Ebola Receive Scarce Drug After Appeals to U.S.

Three Liberian health care workers who have contracted Ebola received an extremely scarce experimental serum on Friday at a hospital outside the national capital, Monrovia, a Liberian health official said Saturday.
The official, Tolbert G. Nyenswah, an assistant minister of health and social welfare, would not say if any of the three were doctors.
The drug, a mix of monoclonal antibodies called ZMapp, has been tested in animals, but has not been studied for safety or effectiveness in humans. It arrived in Liberia on Wednesday after appeals by leaders there to top officials in the United States and a letter from President Ellen Johnson Sirleaf of Liberia to President Obama.
Mapp Biopharmaceutical of San Diego, which provided the drug, said the “available supply of ZMapp has been exhausted.”
Mr. Nyenswah, who picked up the drug when it arrived at the airport and took part in a meeting to discuss which patients should be selected, said the three recipients had signed consent forms stating that they understood the risks and released all parties involved from liability.
He said he did not know how the patients were doing since receiving the drug.
If the treatment works, Mr. Nyenswah said in an interview earlier in the week, “and we can save the doctors here, especially those senior medical doctors that are infected with the virus, then Liberia can be a place to do a mass trial with the drugs.”



Liberian health officials requested the serum after it was...
[Click here to see the rest of this post]
[Click here to read the US CDC Current Update of Ebola]

Sunday, August 17, 2014

Pharmacies Turn Drugs Into Profits, Pitting Insurers vs. Compounders

Today's post was shared by The New York Times and comes from www.nytimes.com



It may be the biggest thing in diaper rash treatment, a custom-made product to soothe a baby’s bottom at the eye-popping price of $1,600.
This is no Desitin or Balmex, or any other brand found in stores. This cream is blended to order in a pharmacist’s lab.
Does it work better than the common treatments? There is little evidence either way. But the sky-high prices commanded by such compounded medicines are drawing the ire of health insurance companies that must pick up the bill. They say the industry is profiteering at their expense.
Compounded medicines are the Savile Row suits of the pharmacy, made to order when common treatments will not suffice. Pharmacists say it is the doctors who decide what to prescribe. But many pharmacies have standard formulations and some promise six-figure incomes to sales representatives who call on doctors.
Besides the $1,600 ointment to treat diaper rash, there was the $8,500 cream to reduce scarring and the $2,300 salve to relieve pain recently billed to Catamaran, a pharmacy benefits manager. Alarmed that its spending on compounded drugs has quintupled in just two years, Catamaran has begun to review such claims more carefully.


Pharmacy benefit managers owned by UnitedHealth and Blue Cross and Blue Shield plans are also reining in spending on compounded drugs, as are insurers like Harvard Pilgrim and various state workers’ compensation plans.
Express Scripts, the largest pharmacy benefits manager, has said it will stop...
[Click here to see the rest of this post]

Starbucks to Revise Policies to End Irregular Schedules for Its 130,000 Baristas

Today's post was shared by Steven Greenhouse and comes from www.nytimes.com



Starbucks announced revisions on Thursday to the way the company schedules its 130,000 baristas, saying it wanted to improve “stability and consistency” in work hours week to week.
The company intends to curb the much-loathed practice of “clopening,” or workers closing the store late at night and returning just a few hours later to reopen, wrote Cliff Burrows, the group president in charge of American stores, in an email to baristas across the country.
He specified that all work hours must be posted at least one week in advance, a policy that has been only loosely followed in the past. Baristas with more than an hour’s commute will be given the option to transfer to more convenient locations, he wrote, adding that scheduling software will be revised to allow more input from managers.
The changes came in response to an article on Wednesday in The New York Times about a single mother struggling to keep up with erratic hours set by automated software.
“This has given us a real opportunity to hear partners’ voices and say, ‘Are we being clear enough, and are our intents and practices being followed?’ ” Mr. Burrows said in a phone interview.
Though Mr. Burrows vowed in his letter to revise the company’s scheduling software, he could not say exactly how in the interview.
The change comes amid a growing push to curb scheduling practices, enabled by sophisticated software, that can cause havoc in employees’...
[Click here to see the rest of this post]

A California Hospital Charged $10,000 for a Cholesterol Test

Today's post was shared by Mother Jones and comes from www.motherjones.com

By now, I assume we all know that hospitals charge widely varying rates for similar procedures. But it's often hard to pinpoint exactly what's going on. Sometimes it's due to the amount of regional competition. Sometimes the procedures in question vary in ways that simple coding schemes don't pick up. Some doctors are better than others. And of course, hospitals inflate their list prices by different amounts.
All that said, be prepared for your jaw to drop:
Researchers studied charges for a variety of tests at 160 to 180 California hospitals in 2011 and found a huge variation in prices. The average charge for a basic metabolic panel, which measures sodium, potassium and glucose levels, among other indicators, was $214. But hospitals charged from $35 to $7,303, depending on the facility. None of the hospitals were identified.
The biggest range involved charges for a lipid panel, a test that measures cholesterol and triglycerides, a type of fat (lipid), in the blood. The average charge was $220, but costs ranged from a minimum of $10 to a maximum of $10,169. Yes, more than $10,000 for a blood test that doctors typically order for older adults, to check their cholesterol levels.
A lipid panel! This is as standardized a procedure as you could ask for. It's fast, highly automated, identical between hospitals, and has no association with the quality of the doctor who ordered the test. You still might see the usual 2:1 or 3:1 difference in prices, but 1000:1?
So what accounts for...
[Click here to see the rest of this post]